Elutia (ELUT) announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management Devices with Premier (PINC). Effective November 15, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the EluPro Antibiotic-Eluting BioEnvelope, the company said in a statement. “We are thrilled to bring EluPro to a broader audience through this new agreement with Premier,” said Dr. Randy Mills, Elutia’s CEO.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELUT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue